These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1721351)

  • 1. CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression.
    Alessiani M; Kusne S; Fung JJ; Torre-Cisneros J; Jain A; Abu-Elmagd K; Takaya S; Cillo U; Martin M; Todo S
    Transplant Proc; 1991 Dec; 23(6):3035-7. PubMed ID: 1721351
    [No Abstract]   [Full Text] [Related]  

  • 2. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients.
    Sakr M; Hassanein T; Gavaler J; Abu-Elmagd K; Fung J; Gordon R; Starzl T; Van Thiel D
    Transplantation; 1992 Apr; 53(4):786-91. PubMed ID: 1373535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of cytomegalovirus infection and disease in orthotopic liver transplant patients immunosuppressed with cyclosporin versus tacrolimus.
    Varo E; Mella C; Martínez J; Tomé J; Otero E; Bustamante M; Castroagudin JF; Regueiro B; Mariño A; González-Quintela A
    Transplant Proc; 2002 Aug; 34(5):1567-8. PubMed ID: 12176488
    [No Abstract]   [Full Text] [Related]  

  • 5. Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation.
    Kusne S; Fung J; Alessiani M; Martin M; Torre-Cisneros J; Irish W; Ondick L; Jain A; Abu-Elmagd K; Takaya S
    Transplant Proc; 1992 Feb; 24(1):429-30. PubMed ID: 1371626
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytomegalovirus infection after liver transplantation: prophylaxis and preemptive treatment--a single-center experience.
    Perrella A; Esposito C; Ioia G; Campanella L; Taglialatela D; Cuomo O
    Transplant Proc; 2010 May; 42(4):1226-8. PubMed ID: 20534267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of the incidence, timing, significance, risk factors, and outcome of cytomegalovirus infection in liver transplant patients with double-drug immunosuppression and no prophylactic antiviral therapy.
    Sanchez-Turrión V; Cuervas-Mons V; Portero F; Barrios C; Garrido A; Albillos A
    Transplant Proc; 1993 Apr; 25(2):1786. PubMed ID: 8385824
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.
    Fung J; Todo S; Abu-Elmagd K; Jain A; Tzakis A; Martin M; Selby R; Bronsther O; Doyle H; Gayowski T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1130. PubMed ID: 7680146
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.
    Bismuth H
    Transplant Proc; 1995 Feb; 27(1):45-9. PubMed ID: 7533415
    [No Abstract]   [Full Text] [Related]  

  • 10. FK 506 versus cyclosporine in pediatric liver transplantation.
    Tzakis AG; Reyes J; Todo S; Green M; Ohya T; Jain A; Abu-Elmagd K; Alessiani M; Fung JJ; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3010-5. PubMed ID: 1721343
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation.
    Andrews WS; Sommerauer J; Conlin C; Moore P
    Transplant Proc; 1996 Apr; 28(2):897-8. PubMed ID: 8623452
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical use of FK 506 in liver transplantation.
    Klintmalm GB
    Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.
    Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Wahlstrom HE; Sanchez-Urdazpal L; Richards T; Crotty P; Beaver S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):665-8. PubMed ID: 7679835
    [No Abstract]   [Full Text] [Related]  

  • 14. FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man.
    Söderdahl G; Groth CG; Angelin B; Duraj F; Einarsson K; Ericzon BG
    Transplant Proc; 1995 Feb; 27(1):1125. PubMed ID: 7533362
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucose metabolism following liver transplantation and immunosuppression with cyclosporine A or FK 506.
    Senninger N; Golling M; Datsis K; Sido B; Herfarth C; Otto G
    Transplant Proc; 1995 Feb; 27(1):1127-8. PubMed ID: 7533364
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK 506 treatment of intractable rejection after liver transplantation.
    Jost U; Winkler M; Ringe B; Rodeck B; Pichlmayr R
    Transplant Proc; 1993 Aug; 25(4):2686-7. PubMed ID: 7689276
    [No Abstract]   [Full Text] [Related]  

  • 18. CMV retinitis and the use of FK 506.
    Paul AA; Leeper HF; Friberg TR
    Transplant Proc; 1991 Dec; 23(6):3042-3. PubMed ID: 1721354
    [No Abstract]   [Full Text] [Related]  

  • 19. FK 506 rescue therapy: early conversion improves efficacy.
    Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1990-1. PubMed ID: 7682359
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients.
    Loss M; Winkler M; Schneider A; Brinkmann C; Manns M; Ringe B; Pichlmayr R
    Transplant Proc; 1995 Feb; 27(1):1136-9. PubMed ID: 7533365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.